Engensis pain treatment checked for Long-Term safety

NCT ID NCT04055090

Completed Symptom relief Sponsor: Helixmith Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 101 people who had previously received either the experimental drug Engensis or a placebo for painful diabetic neuropathy. No new treatment was given; researchers simply monitored participants for 6 months to see if any safety issues or lasting pain relief appeared. The goal was to understand whether Engensis remains safe and effective over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Engensis (VM202)
What this could lead to: If successful, this could show that Engensis provides lasting pain relief for people with painful diabetic neuropathy.
What could go wrong: This is a follow-up study with no new treatment given, so it cannot prove effectiveness. Results depend on the original trial's outcomes, which may not be positive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEUROPATHY, PAINFUL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC NEUROPATHY, PAINFUL PAINFUL DIABETIC NEUROPATHY

Contacts and locations

Locations

Arizona Research Center

Phoenix, Arizona, 85023, United States
Center for Clinical Research

San Francisco, California, 94115, United States
Clinical Research of West Florida

Tampa, Florida, 33603, United States
Clinical Trials, Inc.

Little Rock, Arkansas, 72205, United States
Diablo Clinical Research, Inc.

Walnut Creek, California, 94598, United States
EVMS (Eastern Virginia Medical School)

Norfolk, Virginia, 23510, United States
Innovative Research of West Florida

Clearwater, Florida, 33756, United States
Nerve and Muscle Center of Texas

Houston, Texas, 77030, United States
Neurological Research Institute

Santa Monica, California, 90404, United States
Northern California Research

Sacramento, California, 95821, United States
Rainier Clinical Research Center, Inc.

Renton, Washington, 98057, United States
Raleigh Neurology Associates, P.A.

Raleigh, North Carolina, 27607, United States
The Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
University of Florida McKnight Brain Institute

Gainesville, Florida, 32611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.